Literature DB >> 18049831

Effect of statin therapy on reperfusion arrhythmia in patients who underwent successful primary angioplasty.

Jing-lin Zhao1, Yue-jin Yang, Wei-dong Pei, Yu-hua Sun, Ji-lin Chen, Run-lin Gao.   

Abstract

BACKGROUND: In animal models, pretreatment with statin can prevent reperfusion arrhythmia. In the observational study, we investigated whether pretreatment with statin may prevent reperfusion arrhythmia in patients who underwent primary coronary intervention for acute myocardial infarction (AMI). METHOD AND
RESULTS: A total of 226 consecutive patients who underwent successful primary angioplasty for a first AMI were studied. Reperfusion arrhythmias were defined as all arrhythmias that occurred within 2 h after successful primary angioplasty. The reperfusion arrhythmia was found in 130 of 226 patients. There were no significant differences in clinical characteristics between the patients with and without statin pretreatment. However, the 41 patients receiving statin treatment before admission had lower incidence of the reperfusion arrhythmia than those without it (19.5% and 65.9%, P < 0.01). Multivariable logistic regression analysis revealed that absence of statin pre-treatment was a significant predictor of the reperfusion arrhythmia along with absence of pre-infarction angina and inferior AMI.
CONCLUSION: Pre-treatment with statin could reduce the reperfusion arrhythmias after acute myocardial infarction in human.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18049831     DOI: 10.1007/s00392-007-0606-9

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  20 in total

1.  Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.

Authors:  Jeffrey J Goldberger; Haris Subacius; Andi Schaechter; Adam Howard; Ronald Berger; Alaa Shalaby; Joseph Levine; Alan H Kadish
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

2.  Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease.

Authors:  A N Pehlivanidis; V G Athyros; D S Demitriadis; A A Papageorgiou; V J Bouloukos; A G Kontopoulos
Journal:  Atherosclerosis       Date:  2001-08       Impact factor: 5.162

3.  Relation of inflammation and benefit of statins after percutaneous coronary interventions.

Authors:  Albert W Chan; Deepak L Bhatt; Derek P Chew; Joel Reginelli; Jakob P Schneider; Eric J Topol; Stephen G Ellis
Journal:  Circulation       Date:  2003-03-24       Impact factor: 29.690

4.  Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.

Authors:  Giuseppe Patti; Massimo Chello; Dario Candura; Vincenzo Pasceri; Andrea D'Ambrosio; Elvio Covino; Germano Di Sciascio
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

5.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

6.  Preconditioning reduces QTc value in patients with first non-ST-segment elevation myocardial infarction (NSTEMI).

Authors:  Christodoulos E Papadopoulos; Haralampos I Karvounis; Georgios E Parharidis; Georgios E Louridas
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-10       Impact factor: 1.468

7.  Pravastatin prevents arrhythmias induced by coronary artery ischemia/reperfusion in anesthetized normocholesterolemic rats.

Authors:  Jianguang Chen; Yoshinobu Nagasawa; Bing-Mei Zhu; Masami Ohmori; Ken-ichi Harada; Akio Fujimura; Keitaro Hashimoto
Journal:  J Pharmacol Sci       Date:  2003-09       Impact factor: 3.337

8.  Reperfusion arrhythmia: a marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction.

Authors:  S Goldberg; A J Greenspon; P L Urban; B Muza; B Berger; P Walinsky; P R Maroko
Journal:  Am Heart J       Date:  1983-01       Impact factor: 4.749

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Ischemic preconditioning attenuates capillary no-reflow and leukocyte adherence in postischemic pancreatitis.

Authors:  R Obermaier; E von Dobschuetz; O Drognitz; U T Hopt; S Benz
Journal:  Langenbecks Arch Surg       Date:  2004-01-09       Impact factor: 3.445

View more
  1 in total

1.  Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial.

Authors:  Ahmed A Khattab; Gjin Ndrepepa; Stefanie Schulz; Franz-Josef Neumann; Julinda Mehilli; Heinz Joachim Büttner; Jürgen Pache; Melchior Seyfarth; Josef Dirschinger; Adnan Kastrati; Peter B Berger; Albert Schömig; Gert Richardt
Journal:  Clin Res Cardiol       Date:  2011-02-11       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.